Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinu Abraham

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Pediatric Blood & Cancer|January 13, 2012
18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma modelsAnuradha Soundararajan, Jinu Abraham, Laura D Nelon, et al.
Sarcoma|May 12, 2011
Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse modelJinu Abraham, Laura D Nelon, Courtney B Kubicek, et al.
Journal of Pediatric Hematology/Oncology|December 8, 2011
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse modelSachiko Ohshima-Hosoyama, Monika A Davare, Suresh I Prajapati, et al.
Journal of Virology|December 22, 2017
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING PathwayBryan Gall, Kara Pryke, Jinu Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcomaTohru Hosoyama, Mohammed Imran Aslam, Jinu Abraham, et al.
Molecular Cancer Research : MCR|August 10, 2013
Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar RhabdomyosarcomaM Imran Aslam, Simone Hettmer, Jinu Abraham, et al.
Frontiers in Immunology|August 1, 2020
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific MannerJinu Abraham, Sara Botto, Nobuyo Mizuno, et al.
Plos Pathogens|December 10, 2015
Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging AlphavirusesTina M Sali, Kara M Pryke, Jinu Abraham, et al.
Pediatric Blood & Cancer|March 26, 2013
A case study of personalized therapy for osteosarcomaLara E Davis, Nicolle E Hofmann, Guangheng Li, et al.
Molecular Cancer Therapeutics|March 31, 2011
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcomaJinu Abraham, Suresh I Prajapati, Koichi Nishijo, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|January 13, 2012
18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma modelsAnuradha Soundararajan, Jinu Abraham, Laura D Nelon, et al.
Sarcoma|May 12, 2011
Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse modelJinu Abraham, Laura D Nelon, Courtney B Kubicek, et al.
Journal of Pediatric Hematology/Oncology|December 8, 2011
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse modelSachiko Ohshima-Hosoyama, Monika A Davare, Suresh I Prajapati, et al.
Journal of Virology|December 22, 2017
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING PathwayBryan Gall, Kara Pryke, Jinu Abraham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcomaTohru Hosoyama, Mohammed Imran Aslam, Jinu Abraham, et al.
Molecular Cancer Research : MCR|August 10, 2013
Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar RhabdomyosarcomaM Imran Aslam, Simone Hettmer, Jinu Abraham, et al.
Frontiers in Immunology|August 1, 2020
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific MannerJinu Abraham, Sara Botto, Nobuyo Mizuno, et al.
Plos Pathogens|December 10, 2015
Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging AlphavirusesTina M Sali, Kara M Pryke, Jinu Abraham, et al.
Pediatric Blood & Cancer|March 26, 2013
A case study of personalized therapy for osteosarcomaLara E Davis, Nicolle E Hofmann, Guangheng Li, et al.
Molecular Cancer Therapeutics|March 31, 2011
Evasion mechanisms to Igf1r inhibition in rhabdomyosarcomaJinu Abraham, Suresh I Prajapati, Koichi Nishijo, et al.
Pageof 4